Bradley Prechtl on Factors Oncology Practices Must Consider When Considering an Affiliation Option
March 8th 2020I think a lot of it is, do you trust the people that you're going to be working with? What does it come down to economically? And then I would say on the third end is what can really be done to enhance patient care? As it relates to the decision that you make, said Bradley Prechtl, MBA, chief executive officer of the American Oncology Network.
Watch
Dr Ali McBride Details the Significance of His Presidential Theme in ACCC's 46th Annual Meeting
March 7th 2020My Presidential theme was to look at the interdisciplinary care team involved in the actual delivery of cancer therapies and cancer care, said Ali McBride, PharmD, MS, BCPS, BCOP, clinical coordinator of hematology/oncology in the Department of Pharmacy at The University of Arizona Cancer Center and outgoing president of ACCC.
Watch
Susan Dentzer Discusses Available Innovations in Oncology to Promote Efficient Patient-Centered Care
March 6th 2020There are many applications that are available today that could be brought into the oncology landscape to create a much more patient-centered focus of experiences for those undergoing care, said Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy.
Watch
Through Networks, Collaboration Keeps Oncology Care in the Community
March 4th 2020How can community oncology practices keep up with changing federal regulations and the constant fl ow of new scientific evidence, while delivering quality care in the era of payment reform? The answer, said panelists at Patient-Centered Oncology Care®, is to stay independent by working together.
Read More
Innovation and Novel Therapies
March 3rd 2020During a discussion at The American Journal of Managed Care®’s Patient- Centered Oncology Care® meeting in Philadelphia, panelists outlined the efficacy of the 2 FDA-approved therapies, Medicare reimbursement for CAR T-cell therapies, and the pace of innovation in healthcare.
Read More
From the Editor-in-Chief: The End of the Beginning
February 19th 2020Dr Alvarnas is editor-in-chief of Evidence-Based Oncology.™ He is vice president of Government Affairs, senior medical director for Employer Strategy, and associate clinical professor, Hematology & Hematologic Cell Transplantation, City of Hope, Duarte, Califonia.
Read More
Lessons From the Front: Designing and Implementing Clinical Pathways by and for Clinicians
As cancer care becomes more complex and more expensive, decision-support algorithms offer a mechanism to define best practice, reduce unwarranted variation, and control costs across growing networks.
Read More
This Week in Managed Care: February 7, 2020
February 8th 2020This week, top managed care stories included survey results on oncology practices’ willingness to take on risk; a warning of flu among children in detention centers; study findings establishing a link between circadian rhythm and type 2 diabetes.
Watch
Dr Joshua Ofman: Improving Survival, Reducing Costs in Oncology Vital to Value-Based Care Transition
February 6th 2020From a value-based medicine perspective, we think there's no greater value in the healthcare system than improving survival for cancer patients and reducing the costs of treating late stage cancer; we believe the GRAIL test could be the test case for how to make this transition, said Joshua Ofman, MD, MSHS, chief of Corporate Strategy and External Affairs at GRAIL Inc.
Watch
A Population-Based Assessment of Proton Beam Therapy Utilization in California
This population-based analysis of patients with cancer in California found significant differences in proton beam therapy use by health insurance type, race/ethnicity, and socioeconomic status.
Read More
CMS Agrees to Cover NGS for Medicare Patients With Breast, Ovarian, Other Cancers
January 28th 2020CMS said it is expanding coverage of next generation sequencing (NGS) for use as a diagnostic for patients with germline breast and ovarian cancer, paving the way for Medicare beneficiaries to receive more personalized medicine. However, an advocate said the wording of CMS' decision could actually limit testing access for some women with breast or ovarian cancer.
Read More
Jennifer Atkins Explains How Blue Cross Blue Shield Evaluates Emerging Innovations in Cancer Care
January 17th 2020Blue Cross Blue Shield utilizes data to drive insights into what works and what doesn't work in cancer care, as well as, delineating trends through our collaboration with provider specialties and organizations across the US, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
Watch
When Less Is More: Halving Chemo Keeps Testicular Cancer at Bay, Study Finds
January 4th 2020Testicular cancer is the most common cancer to be diagnosed in men as younger men—those younger than age 40—and it can be particularly aggressive. Advances in therapy have improved survival rates, but if young men have chemotherapy after surgery, they may live with side effects for decades.
Read More
What We're Reading: Healthcare Issues to Watch; e-Cig Flavor Ban; Google AI and Breast Cancer
January 2nd 2020Five issues in healthcare were spotlighted as key developments to watch; FDA to ban all e-cig vape flavors except for menthol and tobacco; Google AI system shown to improve detection of breast cancer through mammograms.
Read More
An Immune-Suppressing Target for Glioblastoma?
December 27th 2019A team at The University of Texas MD Anderson Cancer Center in Houston led by original pioneers in immuno-oncology have published a paper in Nature Medicine that discusses an immune-suppressing enzyme that was strongly present in glioblastoma but not in 5 other tumor types the team studied.
Read More
Improving Survival in Lung Cancer: Commitment of The Lung Ambition Alliance
December 19th 2019For more than 45 years, the International Association for the Study of Lung Cancer has been working tirelessly toward a world without lung and other thoracic cancers. To add strength to our efforts we recently joined with other leading organizations in the lung cancer space to create a powerful force for change: The Lung Ambition Alliance
Read More